Grupo 2: Biología Molecular del VIH

Código de grupo: 5.02
Tipo de grupo: Consolidado
Descripción del grupo: Biología molecular del VIH
Jefe de Grupo: Dra. Mª Ángeles Muñoz Fernández

Integrantes del grupo
Investigadores y personal de apoyo
ALMALE ASO MARIA ÁNGELES First Stage Researcher
CAÑADILLA MARTIN VANESSA Laboratory Technician
ESPINAR BUITRAGO MARÍA DE LA SIERRA
GALLEGO DE LA FUENTE JORGE LUIS Laboratory Technician
GARCIA ALONSO MARIA DOLORES First Stage Researcher
GARCIA PEREZ DE LA LASTRA CRISTINA
GOMEZ RICO CORAL Leading Researcher
HERNANZ LOBO ALICIA Recognised Researcher
JIMENEZ FUENTES JOSE LUIS First Stage Researcher
MAGRO LOPEZ ESMERALDA Recognised Researcher
MAULEON AZPILICUETA MARIA ELVA Leading Researcher
MUÑOZ FERNANDEZ MARIA ANGELES Leading Researcher
RODRÍGUEZ IZQUIERDO IGNACIO First Stage Researcher
RODRIGUEZ RELAÑO IGNACIO
ROYO RUBIO ELENA
SERRAMÍA LOBERA MARIA JESÚS Laboratory Technician
TARANCON DIEZ LAURA Recognised Researcher
VÁZQUEZ ALEJO ELENA
Líneas de Investigación
Axis 1. Basic Research

L1: The use of nanoparticles as miRNA delivery agents

L2: Use of nanoparticles, mainly dendrimers, as microbicides against HIV-1, HSV and other sexually transmitted viruses

L3: Generation of organoids from human pluripotent stem cells: a platform for modeling infectious diseases. Nanotechnology-based therapies.

Axis 2. Clinical Research

L1: Design of immunomodulators and therapeutic vaccines based on dendritic cells against HIV and other sexually transmitted viruses

L2: Paediatric infection by HIV and other viruses

 

L3: Study of SARS-CoV2 infection in adult population and HIV/SARS-Co2 coinfection

Axis 3 BioBank

L1: Participation in clinical trials

L2: Private sample collections for specific projects and coordinated by the Director of the HGM HIV biobank, Dr. Muñoz-Fernández, the HGUGM has several cohorts of patients, such as the broncholitis cohort, neonatology, nephrology, rare diseases, respiratory diseases, sepsis, tuberculosis and the recent GesNEO cohort (pregnant women infected by SARS-CoV2 and their newborns) with biological samples stored in the BioBank

 

First decile publications 1 10,2
First quartile publications 16 108,1
Second quartile publications 5 18,8
Third quartile publications 3 8,4
Total publications (including those without IF) 27 137,5

 

 

 

 

 

 

 

 

 

 

 

SUBIR ↑